DAILY VERSUS ALTERNATE-DAY ROSUVASTATIN FOR DYSLIPIDEMIA: A RANDOMIZED CONTROLLED STUDY. Int. Res. J. Pharm. [Internet]. 2026 Mar. 9 [cited 2026 Jul. 29];17(3):1-11. Available from: https://irjponline.org/index.php/irjp/article/view/3447